PRISMASOL BK 4 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prismasol Bk 4, and when can generic versions of Prismasol Bk 4 launch?
Prismasol Bk 4 is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.
The generic ingredient in PRISMASOL BK 4 is calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride. There are two hundred and eighty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRISMASOL BK 4?
- What are the global sales for PRISMASOL BK 4?
- What is Average Wholesale Price for PRISMASOL BK 4?
Summary for PRISMASOL BK 4
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PRISMASOL BK 4 at DailyMed |
US Patents and Regulatory Information for PRISMASOL BK 4
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER | calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride | INJECTABLE;INJECTION | 021703-009 | Oct 25, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
